Jonosteril Na 100 Kohlenhydratfrei (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Sod)

Magnesium chloride hexahydrate dissociates in the bloodstream to release magnesium ions, which act as cofactors for many enzymatic reactions, help regulate muscle and nerve function, and contribute to the stability of cardiac rhythm. In the context of Jonosteril Na 100, it assists in correcting magnesium deficits while the solution provides other essential electrolytes.

The dose of Jonosteril Na 100 is determined by the prescribing clinician based on the patient’s fluid status, electrolyte measurements, weight, and clinical condition. The healthcare professional calculates the required volume and infusion rate to safely achieve the desired electrolyte balance.

Safety data for Jonosteril Na 100 in pregnancy and lactation are limited. Use is generally reserved for situations where the benefits to the mother outweigh potential risks to the fetus or infant, and only under close medical supervision. Clinicians should evaluate each case individually.

To order Jonosteril Na 100, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Jonosteril Na 100 provides a balanced combination of sodium, potassium, calcium, magnesium and chloride without added carbohydrates, making it suitable for patients requiring carbohydrate‑free fluid therapy. Compared with generic saline or lactated Ringer’s, it offers a broader electrolyte profile, which can reduce the need for additional supplementation in complex clinical scenarios.

The solution should be stored at 2‑8 °C, protected from light, and must not be frozen. Keep the container in its original packaging to avoid moisture exposure. Before use, inspect for particulate matter or discoloration and ensure the infusion set is compatible with the solution.

Jonosteril Na 100 is administered intravenously using a sterile infusion set. The healthcare provider selects an appropriate infusion rate based on the patient’s clinical needs, monitors vital signs and electrolyte levels, and adjusts the rate as required to achieve the target fluid and electrolyte balance.

Serious risks include severe hypermagnesemia, which can cause respiratory depression and cardiac arrhythmias, as well as volume overload leading to pulmonary edema in patients with compromised cardiac function. Rapid infusion may also precipitate electrolyte‑related arrhythmias. Continuous monitoring is essential to detect these complications early.

Jonosteril Na 100 should be avoided in patients with known hypersensitivity to any of its components, those with uncontrolled hyperkalemia, severe hypernatremia, or untreated severe electrolyte imbalances that could be worsened by the infusion. Clinicians must also consider contraindications in patients with severe renal or cardiac failure where fluid overload is a concern.